HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$5.85
Day range
$5.71 - $5.96
Year range
$5.25 - $22.75
Market cap
436.12M USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 45.06M | 53.58% |
Operating expense | 63.59M | 11.39% |
Net income | -90.17M | -36.99% |
Net profit margin | -200.12 | 10.80% |
Earnings per share | -0.94 | -23.68% |
EBITDA | -73.35M | 8.76% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 566.85M | 25.90% |
Total assets | 788.91M | 17.30% |
Total liabilities | 588.10M | -6.61% |
Total equity | 200.81M | — |
Shares outstanding | 76.10M | — |
Price to book | 2.20 | — |
Return on assets | -25.54% | — |
Return on capital | -32.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -90.17M | -36.99% |
Cash from operations | -70.47M | -28.98% |
Cash from investing | -16.95M | 53.82% |
Cash from financing | 124.00K | -77.50% |
Net change in cash | -86.07M | 3.99% |
Free cash flow | 293.50K | 100.74% |
About
Founded
2008
Website
Employees
380